A Role for Proinflammatory Cytokines and Fractalkine in Analgesia, Tolerance, and Subsequent Pain Facilitation Induced by Chronic Intrathecal Morphine
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
The present experiments examined the role of spinal proinflammatory cytokines [interleukin-1β (IL-1)] and chemokines (fractalkine) in acute analgesia and in the development of analgesic tolerance, thermal hyperalgesia, and tactile allodynia in response to chronic intrathecal morphine. Chronic (5 d), but not acute (1 d), intrathecal morphine was associated with a rapid increase in proinflammatory cytokine protein and/or mRNA in dorsal spinal cord and lumbosacral CSF. To determine whether IL-1 release modulates the effects of morphine, intrathecal morphine was coadministered with intrathecal IL-1 receptor antagonist (IL-1ra). This regimen potentiated acute morphine analgesia and inhibited the development of hyperalgesia, allodynia, and analgesic tolerance. Similarly, intrathecal IL-1ra administered after the establishment of morphine tolerance reversed hyperalgesia and prevented the additional development of tolerance and allodynia. Fractalkine also appears to modulate the effects of intrathecal morphine because coadministration of morphine with intrathecal neutralizing antibody against the fractalkine receptor (CX3CR1) potentiated acute morphine analgesia and attenuated the development of tolerance, hyperalgesia, and allodynia. Fractalkine may be exerting these effects via IL-1 because fractalkine (CX3CL1) induced the release of IL-1 from acutely isolated dorsal spinal cord in vitro. Finally, gene therapy with an adenoviral vector encoding for the release of the anti-inflammatory cytokine IL-10 also potentiated acute morphine analgesia and attenuated the development of tolerance, hyperalgesia, and allodynia. Taken together, these results suggest that IL-1 and fractalkine are endogenous regulators of morphine analgesia and are involved in the increases in pain sensitivity that occur after chronic opiates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610
Quantitative assessment of tactile allodynia in the rat paw
Chaplan, S. R., Bach, F. W., Pogrel, J. W., Chung, J. M., & Yaksh, T. L. (1994) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(94)90144-9 · Cited by 7,697
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
GLIA: A novel drug discovery target for clinical pain
Watkins, L. R., & Maier, S. F. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1251 · Cited by 672
Self-citationMolecular Mechanisms and Regulation of Opioid Receptor Signaling
Law, P.-Y., Wong, Y. H., & Loh, H. H. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.389 · Cited by 661
Raghavendra, V., Rutkowski, M. D., & DeLeo, J. A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-22-09980.2002 · Cited by 469
Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy
Mao, J. (2002) · Pain · doi:10.1016/s0304-3959(02)00422-0 · Cited by 462
The involvement of glial cells in the development of morphine tolerance
Song, P., & Zhao, Z.-Q. (2001) · Neuroscience Research · doi:10.1016/s0168-0102(00)00226-1 · Cited by 445
Cited by
Pathological and protective roles of glia in chronic pain
Milligan, E. D., & Watkins, L. R. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2533 · Cited by 1,399
Self-citationOpioid-induced Hyperalgesia: A Qualitative Systematic Review
Angst, M. S., & Clark, J. D. (2006) · Anesthesiology · doi:10.1097/00000542-200603000-00025 · Cited by 1,188
Glia and pain: Is chronic pain a gliopathy?
Ji, R.-R., Berta, T., & Nedergaard, M. (2013) · Pain · doi:10.1016/j.pain.2013.06.022 · Cited by 1,187
Models and Mechanisms of Hyperalgesia and Allodynia
Sandkühler, J. (2009) · Physiological Reviews · doi:10.1152/physrev.00025.2008 · Cited by 1,148
A Comprehensive Review of Opioid-Induced Hyperalgesia
Lee, M. O. (2011) · Pain Physician · doi:10.36076/ppj.2011/14/145 · Cited by 1,118
Interactions between the immune and nervous systems in pain
Ren, K., & Dubner, R. (2010) · Nature Medicine · doi:10.1038/nm.2234 · Cited by 814
Neuropathic pain: mechanisms and their clinical implications
Cohen, S. P., & Mao, J. (2014) · BMJ · doi:10.1136/bmj.f7656 · Cited by 802
Opioid-induced Hyperalgesia in Humans: Molecular Mechanisms and Clinical Considerations
Chu, L. F., Angst, M. S., & Clark, D. (2008) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e31816b2f43 · Cited by 575
Evidence that opioids may have toll-like receptor 4 and MD-2 effects
Hutchinson, M. R., Zhang, Y., Shridhar, M., Evans, J. H., Buchanan, M. M., Zhao, T. X., Slivka, P. F., Coats, B. D., Rezvani, N., Wieseler, J., et al. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.08.004 · Cited by 573
Self-citationImportance of glial activation in neuropathic pain
Mika, J., Zychowska, M., Popiolek-Barczyk, K., Rojewska, E., & Przewlocka, B. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.072 · Cited by 460
Watkins, L. R., Hutchinson, M. R., Rice, K. C., & Maier, S. F. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.08.002 · Cited by 438
“Morphine withdrawal-induced pain enhancement suppressed IL-10 [ 32 ], IL-1ra [32], propentofylline (SLC022) [33],”
BackgroundInfluentialSelf-citationHutchinson, M. R., Shavit, Y., Grace, P. M., Rice, K. C., Maier, S. F., & Watkins, L. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.004135 · Cited by 397
Self-citationOpioid-induced hyperalgesia: Cellular and molecular mechanisms
Roeckel, L.-A., Le Coz, G.-M., Gavériaux-Ruff, C., & Simonin, F. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.06.029 · Cited by 388
Zhuang, Z.-Y., Kawasaki, Y., Tan, P.-H., Wen, Y.-R., Huang, J., & Ji, R.-R. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.11.003 · Cited by 371
Cytokine and Chemokine Regulation of Sensory Neuron Function
Miller, R. J., Jung, H., Bhangoo, S. K., & White, F. A. (2009) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-79090-7_12 · Cited by 364
Hutchinson, M. R., Bland, S. T., Johnson, K. W., Rice, K. C., Maier, S. F., & Watkins, L. R. (2007) · The Scientific World JOURNAL · doi:10.1100/tsw.2007.230 · Cited by 359
“A second thread of evidence was the work of Johnston et al.[7], which suggested glial involvement in morphine withdrawal induced pain enhancement, as this enhanced nociception could be blocked by IL1ra or IL-10.”
BackgroundInfluentialSelf-citationDrug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337
Glia: novel counter-regulators of opioid analgesia
Watkins, L. R., Hutchinson, M. R., Johnston, I. N., & Maier, S. F. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.10.001 · Cited by 328
Self-citationWatkins, L. R., Hutchinson, M. R., Ledeboer, A., Wieseler-Frank, J., Milligan, E. D., & Maier, S. F. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.10.011 · Cited by 326
Self-citationOpioid-Induced Tolerance and Hyperalgesia
Mercadante, S., Arcuri, E., & Santoni, A. (2019) · CNS Drugs · doi:10.1007/s40263-019-00660-0 · Cited by 326
Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia
Hutchinson, M. R., Coats, B. D., Lewis, S. S., Zhang, Y., Sprunger, D. B., Rezvani, N., Baker, E. M., Jekich, B. M., Wieseler, J. L., Somogyi, A. A., et al. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.05.004 · Cited by 306
Self-citationHutchinson, M. R., Lewis, S. S., Coats, B. D., Skyba, D. A., Crysdale, N. Y., Berkelhammer, D. L., Brzeski, A., Northcutt, A., Vietz, C. M., Judd, C. M., et al. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.09.012 · Cited by 303
Self-citationChemokines: Integrators of Pain and Inflammation
White, F. A., Bhangoo, S. K., & Miller, R. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1852 · Cited by 280
Detloff, M. R., Fisher, L. C., McGaughy, V., Longbrake, E. E., Popovich, P. G., & Basso, D. M. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.04.009 · Cited by 273
Neuron–glia crosstalk gets serious: role in pain hypersensitivity
Ren, K., & Dubner, R. (2008) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e32830edbdf · Cited by 269
Peripheral mechanisms of pain and analgesia
Stein, C., Clark, J. D., Oh, U., Vasko, M. R., Wilcox, G. L., Overland, A. C., Vanderah, T. W., & Spencer, R. H. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.12.017 · Cited by 269
Bilbo, S. D., Biedenkapp, J. C., Der-Avakian, A., Watkins, L. R., Rudy, J. W., & Maier, S. F. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1748-05.2005 · Cited by 251
“Primer specificity (Proligo, Boulder, CO) has been verified previously in our laboratory by melt curve analysis (Johnston et al., 2004).”
BackgroundChemokines in chronic pain: cellular and molecular mechanisms and therapeutic potential
Jiang, B.-C., Liu, T., & Gao, Y.-J. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107581 · Cited by 237
Eidson, L. N., & Murphy, A. Z. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1609-13.2013 · Cited by 222
“, fractalkine, dynorphin, and nitric oxide), and astrocytes can express TLR4 (Nichols et al., 1997; Lehnardt et al., 2003; Johnston et al., 2004; Watkins et al., 2005).”
BackgroundAn overview of the cannabinoid type 2 receptor system and its therapeutic potential
Bie, B., Wu, J., Foss, J. F., & Naguib, M. (2018) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000616 · Cited by 206
Watkins, L. R., Hutchinson, M. R., Milligan, E. D., & Maier, S. F. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.06.006 · Cited by 185
Self-citationLewis, S. S., Hutchinson, M. R., Rezvani, N., Loram, L. C., Zhang, Y., Maier, S. F., Rice, K. C., & Watkins, L. R. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2009.10.011 · Cited by 184
“using the QuantiTect SYBR Green PCR Kit (Qiagen) in iCycler iQ 96 well PCR plates (BioRad) on a MyiQ Single Color Real-Time PCR Detection System (Bio-Rad), as previously described (Johnston et al., 2004).”
MethodInfluentialSelf-citationHutchinson, M. R., Lewis, S. S., Coats, B. D., Rezvani, N., Zhang, Y., Wieseler, J. L., Somogyi, A. A., Yin, H., Maier, S. F., Rice, K. C., et al. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.02.011 · Cited by 181
Self-citationXu, J.-T., Zhao, J.-Y., Zhao, X., Ligons, D., Tiwari, V., Atianjoh, F. E., Lee, C.-Y., Liang, L., Zang, W., Njoku, D., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci70236 · Cited by 169
“Chronic exposure to morphine leads to activation of astrocytes and microglia, increases in expression of various signaling receptors in their bodies, and release of proinflammatory cytokines in dorsal horn (7, 38, 39).”
Attenuation of morphine tolerance by minocycline and pentoxifylline in naive and neuropathic mice
Mika, J., Wawrzczak-Bargiela, A., Osikowicz, M., Makuch, W., & Przewlocka, B. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.07.005 · Cited by 163
The dark side of opioids in pain management: basic science explains clinical observation
Rivat, C., & Ballantyne, J. (2016) · PAIN Reports · doi:10.1097/pr9.0000000000000570 · Cited by 160
Allostatic mechanisms of opioid tolerance beyond desensitization and downregulation
Cahill, C. M., Walwyn, W., Taylor, A. M. W., Pradhan, A. A. A., & Evans, C. J. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.08.002 · Cited by 122
Frank, M. G., Watkins, L. R., & Maier, S. F. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.01.005 · Cited by 116
“In addition, blockade of morphine-induced IL-1b signaling potentiated morphine analgesia and prevented the development of hyperalgesia and morphine tolerance (Johnston et al., 2004).”
BackgroundSelf-citationD'Haese, J. G., Demir, I. E., Friess, H., & Ceyhan, G. O. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903540265 · Cited by 116
“Neutralizing antibodies to CX3CR1 blocked and attenuated neuropathic pain (Table 1) [46,50,52].”
BackgroundLauro, C., Di Angelantonio, S., Cipriani, R., Sobrero, F., Antonilli, L., Brusadin, V., Ragozzino, D., & Limatola, C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7590 · Cited by 110
“T he chemokine fractalkine (CX3CL1) and its specific receptor, CX3CR1, are constitutively expressed throughout the CNS, (1) where in addition to modulating neurotransmission (2), they play the pathophysiological role of regulating microglial neurotoxicity (3, 4), neuropathic nociception (5), NK cell recruitment (6), a…”
BackgroundMerighi, S., Gessi, S., Varani, K., Fazzi, D., Mirandola, P., & Borea, P. A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01948.x · Cited by 79
“Repeated morphine treatment can activate glia and hence up-regulate these various mediators (Raghavendra et al., 2002; 2004; Johnston et al., 2004; Watkins et al., 2005) through the MAPK, PKC and PI3K/Akt pathways, key players in the intracellular signalling cascade leading to the development of…”
BackgroundThe role of TNFα in the periaqueductal gray during naloxone-precipitated morphine withdrawal in rats
Hao, S., Liu, S., Zheng, X., Zheng, W., Ouyang, H., Mata, M., & Fink, D. J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.197 · Cited by 74
“Chronic administration of systemic or intrathecal morphine activates spinal glia cells with downstream upregulation of proinflammatory cytokines (”
BackgroundLiang, D., Shi, X., Qiao, Y., Angst, M. S., Yeomans, D. C., & Clark, J. D. (2008) · Molecular Pain · doi:10.1186/1744-8069-4-7 · Cited by 71
Bjurstrom, M. F., Giron, S. E., & Griffis, C. A. (2016) · Pain Practice · doi:10.1111/papr.12252 · Cited by 62
“Opioid treatment, through activation of glial cells, triggers increase of proinflammatory cytokines, which oppose opioid analgesia, and in experimental settings, inhibition of proinflammatory cytokines has increased opioid efficacy and reduced tolerance and hyperalgesia.(144,145) As described above, the study by Zin e…”
BackgroundParaquat-induced inflammatory response of microglia through HSP60/TLR4 signaling
Sun, Y., Zheng, J., Xu, Y., & Zhang, X. (2018) · Human & Experimental Toxicology · doi:10.1177/0960327118758152 · Cited by 61
Mansouri, M. T., Naghizadeh, B., Ghorbanzadeh, B., Alboghobeish, S., Amirgholami, N., Houshmand, G., & Cauli, O. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.02.009 · Cited by 39
Metadata
- Authors
- Johnston, I. N., Milligan, E. D., Wieseler-Frank, J., Frank, M. G., Zapata, V., Campisi, J., Langer, S., Martin, D., Green, P., Fleshner, M., Leinwand, L., Maier, S. F., & Watkins, L. R.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2004-08-18
- Volume
- 24
- Issue
- 33
- Pages
- 7353-7365
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2124673849
- Cited by
- 433
- References
- 56
- FWCI
- 9.31
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.